Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125819241 | 12581924 | 1 | I | 20150618 | 20160722 | 20160722 | EXP | 2015216695 | US-STRIDES ARCOLAB LIMITED-2015SP000881 | STRIDES | 0.00 | Y | 0.00000 | 20160722 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125819241 | 12581924 | 1 | PS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | 500 MG, BID | Y | 90055 | 500 | MG | ||||||||
| 125819241 | 12581924 | 2 | SS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | 250 MG, BID | Y | 90055 | 250 | MG | ||||||||
| 125819241 | 12581924 | 3 | C | TACROLIMUS. | TACROLIMUS | 1 | 5 MG, BID | 0 | 5 | MG | |||||||||
| 125819241 | 12581924 | 4 | C | TACROLIMUS. | TACROLIMUS | 1 | 3 MG, BID | 0 | 3 | MG | |||||||||
| 125819241 | 12581924 | 5 | C | TACROLIMUS. | TACROLIMUS | 1 | 2 MG, BID | 0 | 2 | MG | |||||||||
| 125819241 | 12581924 | 6 | C | PREDNISOLONE. | PREDNISOLONE | 1 | 30 MG, QD | 0 | 30 | MG | |||||||||
| 125819241 | 12581924 | 7 | C | PREDNISOLONE. | PREDNISOLONE | 1 | 5 UNK, UNK | 0 | 5 | MG | |||||||||
| 125819241 | 12581924 | 8 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 5 MG, QD | 0 | 5 | MG | |||||||||
| 125819241 | 12581924 | 9 | C | SULFAMETHOXAZOLE AND TRIMETHOPRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | UNK | 0 | |||||||||||
| 125819241 | 12581924 | 10 | C | VALGANCICLOVIR. | VALGANCICLOVIR | 1 | UNK | 0 | |||||||||||
| 125819241 | 12581924 | 11 | C | NYSTATIN. | NYSTATIN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125819241 | 12581924 | 1 | Immunosuppressant drug therapy |
| 125819241 | 12581924 | 3 | Immunosuppressant drug therapy |
| 125819241 | 12581924 | 6 | Product used for unknown indication |
| 125819241 | 12581924 | 8 | Hypertension |
| 125819241 | 12581924 | 9 | Infection prophylaxis |
| 125819241 | 12581924 | 10 | Infection prophylaxis |
| 125819241 | 12581924 | 11 | Infection prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125819241 | 12581924 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125819241 | 12581924 | Diarrhoea | |
| 125819241 | 12581924 | Leukopenia | |
| 125819241 | 12581924 | Neutropenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |